Detailed information for compound 1792931

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 726.746 | Formula: C28H40F6N2O9S2
  • H donors: 2 H acceptors: 6 LogP: 5.91 Rotable bonds: 13
    Rule of 5 violations (Lipinski): 2
  • SMILES: FC(S(=O)(=O)[O-])(F)F.FC(S(=O)(=O)[O-])(F)F.COc1cc2C[N+](C)(CCCCCCCc3cccc([n+]3C)OC)CCc2cc1OC
  • InChi: 1S/C26H40N2O3.2CHF3O3S/c1-27-23(13-11-14-26(27)31-5)12-9-7-6-8-10-16-28(2)17-15-21-18-24(29-3)25(30-4)19-22(21)20-28;2*2-1(3,4)8(5,6)7/h11,13-14,18-19H,6-10,12,15-17,20H2,1-5H3;2*(H,5,6,7)/q+2;;/p-2
  • InChiKey: BSUMSWVFHNXTDM-UHFFFAOYSA-L  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens acetylcholinesterase (Yt blood group) Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus granulosus acetylcholinesterase Get druggable targets OG5_126875 All targets in OG5_126875
Brugia malayi Carboxylesterase family protein Get druggable targets OG5_126875 All targets in OG5_126875
Schistosoma japonicum ko:K01049 acetylcholinesterase [EC3.1.1.7], putative Get druggable targets OG5_126875 All targets in OG5_126875
Loa Loa (eye worm) carboxylesterase Get druggable targets OG5_126875 All targets in OG5_126875
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126875 All targets in OG5_126875
Echinococcus multilocularis acetylcholinesterase Get druggable targets OG5_126875 All targets in OG5_126875
Loa Loa (eye worm) acetylcholinesterase 1 Get druggable targets OG5_126875 All targets in OG5_126875
Echinococcus multilocularis acetylcholinesterase Get druggable targets OG5_126875 All targets in OG5_126875
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126875 All targets in OG5_126875
Brugia malayi Carboxylesterase family protein Get druggable targets OG5_126875 All targets in OG5_126875
Echinococcus granulosus carboxylesterase 5A Get druggable targets OG5_126875 All targets in OG5_126875
Echinococcus granulosus acetylcholinesterase Get druggable targets OG5_126875 All targets in OG5_126875
Schistosoma japonicum Acetylcholinesterase 1 precursor, putative Get druggable targets OG5_126875 All targets in OG5_126875
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) Get druggable targets OG5_126875 All targets in OG5_126875
Echinococcus multilocularis carboxylesterase 5A Get druggable targets OG5_126875 All targets in OG5_126875

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi Carboxylesterase family protein acetylcholinesterase (Yt blood group) 614 aa 510 aa 26.5 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) hypothetical protein 0.1263 0.7922 0.904
Plasmodium falciparum lysine-specific histone demethylase 1, putative 0.0328 0 0.5
Plasmodium falciparum conserved Plasmodium protein, unknown function 0.0328 0 0.5
Brugia malayi SWIRM domain containing protein 0.1362 0.8764 1
Plasmodium falciparum protoporphyrinogen oxidase 0.0328 0 0.5
Onchocerca volvulus 0.1362 0.8764 0.5
Trypanosoma cruzi UDP-galactopyranose mutase 0.0328 0 0.5
Toxoplasma gondii histone lysine-specific demethylase LSD1/BHC110/KDMA1A 0.0328 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0427 0.0841 0.096
Mycobacterium leprae PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) 0.0328 0 0.5
Plasmodium vivax protoporphyrinogen oxidase, putative 0.0328 0 0.5
Mycobacterium ulcerans flavin-containing monoamine oxidase AofH 0.1508 1 1
Loa Loa (eye worm) hypothetical protein 0.1362 0.8764 1
Loa Loa (eye worm) hypothetical protein 0.1263 0.7922 0.904
Schistosoma mansoni Lysine-specific histone demethylase 1 0.1263 0.7922 1
Chlamydia trachomatis protoporphyrinogen oxidase 0.0328 0 0.5
Trypanosoma cruzi UDP-galactopyranose mutase 0.0328 0 0.5
Plasmodium vivax hypothetical protein, conserved 0.0328 0 0.5
Plasmodium vivax lysine-specific histone demethylase 1, putative 0.0328 0 0.5
Echinococcus granulosus lysine specific histone demethylase 1A 0.1263 0.7922 1
Echinococcus multilocularis lysine specific histone demethylase 1A 0.1263 0.7922 1
Mycobacterium tuberculosis Probable flavin-containing monoamine oxidase AofH (amine oxidase) (MAO) 0.118 0.7222 1
Leishmania major UDP-galactopyranose mutase 0.0328 0 0.5
Brugia malayi amine oxidase, flavin-containing family protein 0.0427 0.0841 0.096
Plasmodium vivax hypothetical protein, conserved 0.0328 0 0.5
Toxoplasma gondii histone lysine-specific demethylase 0.0328 0 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 0.049 uM Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured at initial time point by Ellmans method ChEMBL. 24076173
IC50 (binding) = 0.11 uM Reversible inhibition of human recombinant AChE using acetylthiocholine iodide as substrate measured after 2 hrs by Ellmans method ChEMBL. 24076173

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.